Page 2797 - Cote clinical veterinary advisor dogs and cats 4th
P. 2797

1460  Drug Formulary                                                  Acetylcysteine (Mucomyst, N-acetylcysteine, NAC, ACC)



            Drug Formulary
  VetBooks.ir  The drugs listed in this formulary represent a compilation of many of   details of individual drugs is too voluminous to be listed in this format.

                                                                Therefore, it remains the clinician’s responsibility  to  ensure that the
           the therapeutic agents used in small animal practice, without implying
           endorsement  (or  lack  thereof)  of  specific  medications.  Not  all  drugs   particulars of any drug are appropriate for the intended application. The
           used in veterinary practice are included, and some of those listed may be   clinician should recheck drug dosages for accuracy as well as for specific
           used infrequently. Drugs are organized in alphabetical order by generic   indications, contraindications, and warnings. Again, the clinician needs
           names, with trade names or often used synonyms in parentheses. The   to identify the specific and recommended indications for each drug by
           web version of the text also includes a cross-reference with many of   reviewing relevant information (e.g., product insert, primary sources)
           the trade names/synonyms listed alphabetically. We hope that this can   before prescribing, recommending, or using a drug.
           help you to find the drug of interest on those occasions in which the   Although limitations of space do not allow inclusion in print, we encour-
           brand name (e.g., Prozac) is commonly used and the generic name (e.g.,   age readers to avail themselves of additional drug-related information found
           fluoxetine) just does not come readily to mind. Abbreviations used in   in the web version of this text. This includes information regarding important
           the formulary are first defined on this page for the reader’s reference.  interactions between veterinary drugs, drugs of concern when administered
             Canine and feline dosages are listed separately in the second and third   to dogs with MDR1/ABCB1-Δ, charts comparing composition of fluid
           columns, respectively. (The unit of measure of micron, sometimes denoted   types, relative potency of various preparations of glucocorticoids, and more.
           by the Greek letter μ, is abbreviated in this text by mc. For example, 1 mcL   Materials presented are taken from several sources: 1) drug-related informa-
           = 1 microliter; 1 mcg = 1 microgram.) The fourth column, titled Adverse   tion from the other sections of this textbook; 2) the clinical experience of the
           Effects/Warnings, describes important side effects or contraindications   editors and previous redactors of this formulary; 3) Plumb DC: Veterinary
           for each drug. A fifth column, titled Administration/Availability, includes   Drug Handbook, ed 9, Ames, IA, 2018, Wiley; 4) Papich MG: Saunders
           formulations and important notes about administration. This column   Handbook of Veterinary Drugs: Small and Large Animal, ed 3, St. Louis,
           also denotes the Controlled Substance Schedules (CSS) as listed by the   2011; 5) Ramsey I: BSAVA Formulary, Part A: Canine and Feline, ed 9, 2017,
           U.S. Drug Enforcement Administration.                Wiley; 6) VIN Veterinary Drug Handbook, www.vin.com. The editors thank
             While every effort has been made to include clinically useful,   Drs. Steve Ettinger and Wayne Schwark for their important contributions
           important, and  accurate  information,  a comprehensive  review  of  the   to the original version of this Formulary in the first edition of this textbook.

           ABBREVIATIONS
           AAFP: American Association of Feline Practitioners   KCS: keratoconjunctivitis sicca
           BSA: body surface area                               LDDST: low-dose dexamethasone suppression test
           BW: body weight                                      MAO: monamine oxidase
           CHF: congestive heart failure                        mcg: microgram
           CNS: central nervous system                          mcL: microliter
           CRI: constant rate infusion                          MDR1/ABCB1-Δ: genetic mutation of P-glycoprotein
           CSS: controlled substance schedule                   MUE: meningitis encephalitis of unknown etiology
           D 5 W: sterile 5% dextrose in water                  NIOSH: National Institute for Occupational Safety and Health
           DCM: dilated cardiomyopathy                          NSAIDs: nonsteroidal antiinflammatory drugs
           DKA: diabetic ketoacidosis                           OA: affected eye
           DM: diabetes mellitus                                OTC: over-the-counter
           FDA: Food and Drug Administration                    PCV: packed cell volume
           GI: gastrointestinal                                 PO: per os (oral)
           h: hour(s)                                           prn: as needed
           HDDST: high-dose dexamethasone suppression test      PU/PD: polyuria/polydipsia
           IBD: inflammatory bowel disease                      q: every
           IM: intramuscular                                    SQ: subcutaneous
           IV: intravenous                                      SVT: supraventricular tachycardia
           IVDD: intervertebral disc disease                    U: unit(s)
           A


            Generic Name (Brand                                                                 Administration/
            Name, Synonyms)   Canine Dosages        Feline Dosages       Adverse Effects/Warnings  Availability
            Acarbose (Precose)  Hypoglycemic agent:   Hypoglycemic agent:   Flatulence, diarrhea common.   Tablets. Give with food.
                                12.5-25 mg/DOG orally q 12h   12.5 mg/CAT orally with each   May contribute to episodes of
                                with each meal. Can increase   meal q 12h. Can increase   hypoglycemia.
                                dose to 50 mg/DOG q 12h.  dose to 25 mg/CAT q 12h.
            Acetylcysteine (Mucomyst,   Hepatoprotection/antidote:   Hepatoprotection: Dilute 10%   Sulfurlike odor, bronchospasm   Tablets, solutions for
             N-acetylcysteine, NAC,   Dilute 10% sterile NAC with   sterile NAC with sterile saline   if inhaled, GI distress for oral   inhalation. Solutions
             ACC)               sterile saline 1 : 4; administer   1 : 4; administer 140 mg/kg IV   routes.  must be sterilized with a
                                140 mg/kg IV over 20 minutes,   over 20 minutes, then 70 mg/     0.22-micron filter before
                                then 70 mg/kg IV q 6h  kg IV q 12h                               injection or use in the
                              Degenerative myelopathy: 25 mg/                                    eye. Dilute 10% solutions
                                kg PO q 8h for 2 weeks, then q                                   1 : 4 with saline before IV
                                8h q other day given concurrently                                administration.
                                with aminocaproic acid
                              Corneal ulceration: 2%-6%
                                solution topically q 2h for 24
                                hours, then q 6-8h for 1 week
                                                     www.ExpertConsult.com
                                                     www .ExpertConsult.com
   2792   2793   2794   2795   2796   2797   2798   2799   2800   2801   2802